je.st
news
Feuerstein: It's Worth Repeating - Vertex Is the Next Gilead
2013-04-20 02:13:14| Biotech - Topix.net
Analysts are rushing to upgrade and slap triple-digit price targets on Vertex because it now appears more likely that the company's cystic fibrosis drug franchise will prove effective for a large swath of the 70,000 people with the genetic lung disease worldwide.
Tags: the
next
worth
repeating
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||